EFFECTS of MORINGA OLEIFERA LEAF POWDERS on HEMATOLOGICAL PROFILES IN PREGNANT WOMEN WITH IRON DEFICIENCY ANAEMIA

Launched by FAKULTAS KEDOKTERAN UNIVERSITAS PADJADJARAN · Mar 9, 2025

Keywords

ClinConnect Summary

This clinical trial is studying the effects of Moringa Oleifera leaf powder on improving blood health in pregnant women who have iron deficiency anemia. Iron deficiency anemia is a condition where there isn't enough iron in the body, which can lead to fatigue and complications during pregnancy for both the mother and baby. This study aims to see if Moringa, a plant known for its nutritional benefits, can help raise hemoglobin levels (the protein in blood that carries oxygen) when taken alongside regular iron tablets.

To participate, women aged 18 to 44 who are pregnant between 28 to 32 weeks and have low hemoglobin levels (between 7 and 11 g/dl) may be eligible. The trial will involve around 72 participants, who will be divided into two groups: one group will receive Moringa capsules with their iron tablets, while the other group will only receive iron tablets. Over the course of 60 days, researchers will monitor their blood health and check for any side effects. This study hopes to provide evidence that Moringa can be a safe and effective way to help pregnant women manage their iron deficiency anemia.

Gender

FEMALE

Eligibility criteria

• • Inclusion Criteria
• 1. Demographic Characteristics:
• • Women aged 18-44 years
• • Married, have a husband and/or family
• • Have an ID card
• 2. Clinical Characteristics:
• • Pregnant with a gestational age of 28 to \<32 weeks
• • Live single fetus
• • Hemoglobin (Hb) 7 - \< 11 g/dl
• • No congenital abnormalities
• • No complication (DM, infection, genetic disease) based on history taking, clinical signs and symptoms and treatment history.
• • Parity \< 4
• 3. Geographical/Administrative Characteristics:
• • The study subjects (pregnant women) were located in the working area of the health facility where the study was conducted.
• • Health Facility where the study was conducted.
• • - Come to the health facility independently or by referral.
• Exclusion Criteria:
• • Pregnant women with high risk who dropped out or could not be followed up and pregnant women who gave birth prematurely.
• • Allergy to Moringa Oleifera leaf micronized powders